Article: Bayer Schering Pharma Presents Innovations in Men's Healthcare at the 22nd Annual Meeting of the European Association of Urology (EAU).

BERLIN, Germany, March 22 /PRNewswire/ -- Bayer Schering Pharma AG, Germany, highlighted their expanded new offerings in Men's Healthcare during a press conference held at the 22nd Annual Meeting of the European Association of Urology (EAU) on March 22, 2007. The event focused on study results from their three products: Levitra(R), Testogel(R) and Nebido(R).

The Real-Life Perception of Efficacy, Attitude, Satisfaction and Safety of Levitra(R) Therapy (REPEAT) study(1) has been designed to help researchers determine why over 50 of couples experiencing sexual problems discontinue treatment. This three year, innovative post marketing surveillance (PMS) study will follow men ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!